Tan, M., Zhao, P., Zhang, L., Ho, Y., Varma, M. V., Neuhoff, S., . . . Huang, S. (2018). Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates. Clin Pharmacol Ther.

Tan, Ming‐Liang, Ping Zhao, Lei Zhang, Yunn‐Fang Ho, Manthena V.S Varma, Sibylle Neuhoff, Thomas D. Nolin, Aleksandra Galetin, and Shiew‐Mei Huang. "Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease On the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates." Clin Pharmacol Ther 2018.

Tan, Ming‐Liang, et al. "Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease On the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates." Clin Pharmacol Ther 2018.